All > Prostate

Hypofractionated Radiation for Prostate Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Kansas Medical Center/ Cancer Center, Kansas City, KSProstate CancerHypofractionated Radiation - Radiation
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

This trial is testing if a new way of treating prostate cancer, ultra-hypofractionation, is effective and has less urinary side effects.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Hypofractionated Radiation Therapy
2
ARM BA: 3 treatments of 7Gy
1
Low Dose Radiation Therapy

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: up to 5 year post radiation

Year 4
Oxidative stress as a predictor of toxicity
Year 4
Biochemical Control Rate
Month 12
Financial Toxicity Measurement
3 year
Radiation Therapy Oncology Group (RTOG) Late Toxicity Rate
90 days
RTOG Acute Toxicity Rate
Year 5
Toxicity Rates

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Hypofractionated Radiation Therapy
3
ARM BA: 3 treatments of 7Gy
2
Low Dose Radiation Therapy

Trial Design

1 Treatment Group

Hypofrac Radiation Therapy
1 of 1

Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Hypofractionated Radiation · No Placebo Group · N/A

Hypofrac Radiation Therapy
Radiation
Experimental Group · 1 Intervention: Hypofractionated Radiation · Intervention Types: Radiation

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 5 year post radiation

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
407 Previous Clinical Trials
160,133 Total Patients Enrolled
11 Trials studying Prostate Cancer
237 Patients Enrolled for Prostate Cancer
Xinglei Shen, MDPrincipal Investigator - University of Kansas Medical Center
University of Kansas Medical Center
2 Previous Clinical Trials
27 Total Patients Enrolled
1 Trials studying Prostate Cancer
27 Patients Enrolled for Prostate Cancer

Eligibility Criteria

Age 18+ · Male Participants · 11 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Men who are able to father a child should not donate sperm during the study and for 90 days after the last treatment.
You do not have any other form of cancer that is currently active.
References

Frequently Asked Questions

Is recruitment still underway for this experiment?

"Precisely. Clinicaltrials.gov documents that, as of September 1st 2020, this investigation is actively seeking enrolment from 30 participants at one medical centre - the study was originally published on March 22nd 2018." - Anonymous Online Contributor

Unverified Answer

How many participants are being enrolled in this research endeavor?

"Indeed, based on the information provided online by clinicaltrials.gov, this study is currently seeking participants. It was posted on March 22nd 2018 and last edited September 1st 2020; with 30 volunteers being sought from a single location." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top